The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.

Members of the Toll/interleukin-1 receptor (TIR) family are of importance for host defense and inflammation. Here we report that the TIR-family member interleukin-33R (IL-33R) cross-activates the receptor tyrosine kinase c-Kit in human and murine mast cells. The IL-33R-induced activation of signal transducer and activator of transcription 3 (STAT3), extracellular signal-regulated kinase 1/2 (Erk1/2), protein kinase B (PKB), and Jun NH(2)-terminal kinase 1 (JNK1) depends on c-Kit and is required to elicit optimal effector functions. Costimulation with the c-Kit ligand stem cell factor (SCF) is necessary for IL-33-induced cytokine production in primary mast cells. The structural basis for this cross-activation is the complex formation between c-Kit, IL-33R, and IL-1R accessory protein (IL-1RAcP). We found that c-Kit and IL-1RAcP interact constitutively and that IL-33R joins this complex upon ligand binding. Our findings support a model in which signals from seemingly disparate receptors are integrated for full cellular responses.

[1]  C. Meisel,et al.  Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses , 1999, The Journal of experimental medicine.

[2]  S. Galli,et al.  The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. , 1992, Journal of immunology.

[3]  K. Weinberg,et al.  Lipid rafts are required for Kit survival and proliferation signals. , 2007, Blood.

[4]  Richard T. Lee,et al.  The IL-33/ST2 pathway: therapeutic target and novel biomarker , 2008, Nature Reviews Drug Discovery.

[5]  S. Tominaga,et al.  Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. , 2005, Human molecular genetics.

[6]  Dirk E. Smith,et al.  Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1 , 2007, The Journal of Immunology.

[7]  H. Kantarjian,et al.  EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation. , 2007, Blood.

[8]  J. Hawiger,et al.  Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1β Signaling Pathway* , 2005, Journal of Biological Chemistry.

[9]  F. Liew,et al.  Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells , 1998, The Journal of experimental medicine.

[10]  S. Akira,et al.  IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. , 2007, Journal of leukocyte biology.

[11]  M. Huber,et al.  IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells , 2007, Proceedings of the National Academy of Sciences.

[12]  P. L. Becker,et al.  Cholesterol Depletion Inhibits Epidermal Growth Factor Receptor Transactivation by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.

[13]  M. Tsai,et al.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity , 2008, Nature Reviews Immunology.

[14]  Dirk E. Smith,et al.  CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. , 2009, The Journal of allergy and clinical immunology.

[15]  B. Holzmann,et al.  Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation. , 2005, International immunology.

[16]  S. Casares,et al.  Analysis of lipid rafts in T cells. , 2004, Molecular immunology.

[17]  H. Lodish,et al.  Interaction of the erythropoietin and stem-cell-factor receptors , 1995, Nature.

[18]  C. Dahinden,et al.  Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. , 2009, Blood.

[19]  K. Ohta,et al.  An IL-1 Cytokine Member, IL-33, Induces Human Basophil Activation via Its ST2 Receptor1 , 2008, The Journal of Immunology.

[20]  S. Galli,et al.  IL-33 can promote survival, adhesion and cytokine production in human mast cells , 2007, Laboratory Investigation.

[21]  C. Chen,et al.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.

[22]  J. Lennartsson,et al.  Synergistic Growth of Stem Cell Factor and Granulocyte Macrophage Colony-stimulating Factor Involves Kinase-dependent and -independent Contributions from c-Kit* , 2004, Journal of Biological Chemistry.

[23]  R. Kastelein,et al.  IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex , 2007, The Journal of Immunology.

[24]  Mindy I. Davis,et al.  A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.

[25]  C. Gabay,et al.  IL‐1, IL‐18, and IL‐33 families of cytokines , 2008, Immunological reviews.

[26]  Andreas Radbruch,et al.  T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Klemenz,et al.  The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. , 1998, Journal of immunology.

[28]  K. Ohta,et al.  Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils , 2008, Laboratory Investigation.

[29]  P. Lavori,et al.  Direct interaction between Kit and the interleukin-7 receptor. , 2007, Blood.

[30]  I. McInnes,et al.  IL-33 exacerbates antigen-induced arthritis by activating mast cells , 2008, Proceedings of the National Academy of Sciences.

[31]  B. Longley,et al.  Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. , 2003, Experimental hematology.

[32]  M. Hayakawa,et al.  TRAF6 is a critical signal transducer in IL-33 signaling pathway. , 2008, Cellular signalling.

[33]  S. Tominaga,et al.  Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface , 2002, European journal of immunology.

[34]  F. Liew,et al.  ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance , 2004, Nature Immunology.

[35]  M. Heidtman,et al.  Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)–mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1) , 1997, The Journal of experimental medicine.

[36]  M. Hayakawa,et al.  Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation* , 2007, Journal of Biological Chemistry.

[37]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[38]  R. Olivenstein,et al.  The expression of stem cell factor and c‐kit receptor in human asthmatic airways , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  A. Zelenetz,et al.  W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. , 1993, Development.

[40]  XuD HepworthMR LiewFY GrencisRK HumphreysNE.  IL-33, a potent inducer of adaptive immunity to intestinal nematodes. , 2008 .

[41]  C. Meisel,et al.  Regulation and Function of T1/ST2 Expression on CD4+ T Cells: Induction of Type 2 Cytokine Production by T1/ST2 Cross-Linking1 , 2001, The Journal of Immunology.

[42]  K. Austen,et al.  Post-transcriptional Stabilization by Interleukin-1β of Interleukin-6 mRNA Induced by c-kit Ligand and Interleukin-10 in Mouse Bone Marrow-derived Mast Cells* , 1996, The Journal of Biological Chemistry.

[43]  Dirk E. Smith,et al.  IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. , 2008, International immunology.

[44]  V. Broudy,et al.  Soluble Kit receptor blocks stem cell factor bioactivity in vitro. , 2001, Leukemia research.

[45]  A. Mui,et al.  Steel factor stimulates the serine/threonine phosphorylation of the interleukin-3 receptor. , 1994, The Journal of biological chemistry.

[46]  M. Gayle,et al.  T1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family (*) , 1996, The Journal of Biological Chemistry.

[47]  S. Akira,et al.  IL‐33 induces IL‐13 production by mouse mast cells independently of IgE‐FcεRI signals , 2007 .

[48]  C. Meisel,et al.  T1/ST2 expression is enhanced on CD4+ T cells from schistosome egg-induced granulomas: analysis of Th cell cytokine coexpression ex vivo. , 1999, Journal of immunology.